Примери за използване на Infusion-related на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Infusion-related reactions.
For clinical management of infusion-related reactions, see section 4.4.
Infusion-related chest pain.
It is not known how frequently infusion-related reactions to this medicine are serious or fatal.
Infusion-related reactions(IRRs).
Serious adverse reactions were immune-related adverse reactions and infusion-related reaction(see section 4.4).
Infusion-related reaction, pain.
Use of concomitant immunosuppressant agents appeared to reduce the frequency of infusion-related reactions.
Infusion-related side effects.
Adverse reactions of an immune nature(e.g. infusion-related reactions or injection-site reactions) are normally not severe.
Infusion-related reactions and hypersensitivity.
This is known as an infusion-related reaction and can sometimes be severe.
Infusion-related, including anaphylactic, reactions.
Serious but uncommon infusion-related reactions include anaphylaxis(severe allergic reaction).
Infusion-related reactions(IRRs) and hypersensitivity.
Severe infusion-related reactions*, fatigue.
Infusion-related reactions Grade 1 infusion-related reaction.
Severe infusion-related reactions were reported in 0.4% of patients.
Infusion-related reaction primarily presented as back pain.
In case of infusion-related reactions to the first 100 mg dose, the second dose should be delayed until day 2.
Infusion-related reactions(IRRs) and hypersensitivity.
The most common infusion-related reaction symptoms/Preferred Terms included headaches, chills, high blood pressure, nausea, asthenia and pain.
Infusion-related problems may also include sudden loss of consciousness.
To reduce the risk of infusion-related reactions, patients may be given other medicines before or during treatment with Inflectra or the infusion time may be slowed down.
Infusion-related side effects and abdominal pain are very common(see section 4).
Other infusion-related symptoms may include dizziness and hyperhidrosis.
Infusion-related reactions(including cytokine-release syndrome, tumour-lysis syndrome).
Infusion-related reactions were reported in clinical studies with ramucirumab.
Infusion-related reactions have been observed with atezolizumab(see section 4.8).
Infusion-related reactions in the pemphigus vulgaris clinical study were common(58%).